Skip to content

Reniba Babu, MD

NPI 1811691637ActiveIndividual· Internal Medicine, Rheumatology· Kansas City, KS

Internal Medicine, Rheumatology (MD) in Kansas City, Kansas, licensed in KS, with an NPI issued in March 2023. Part D covered 124 prescriptions written in 2024, 87% of them generic. Astrazeneca Pharmaceuticals LP reported $106.39 in payments in 2024, mostly food and beverage.

Overview

NPI1811691637
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMar 27, 2023
Last updated in NPPESJul 1, 2026
Certified by providerJul 1, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Rheumatology Primary207RR0500X94-12556KS

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Rheumatology (KS)

Part D prescriptions in 2024

Prescriptions (claims)124 · 149 30-day fills
Patients49
Total drug cost$11,440
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$106.39 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Astrazeneca Pharmaceuticals LP$106.391

What the 2024 payments were for

  • Food and Beverage$106.39 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other rheumatologists in Kansas City

All rheumatologists in Kansas